Home/Filings/4/0001019687-16-004909
4//SEC Filing

Medytox Solutions, Inc. 4

Accession 0001019687-16-004909

CIK 0001374536operating

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 12:23 PM ET

Size

11.5 KB

Accession

0001019687-16-004909

Insider Transaction Report

Form 4
Period: 2015-11-02
Hollis Sharon Lynne
VP of Operations10% Owner
Transactions
  • Disposition to Issuer

    Options to Purchase Common Stock

    2015-11-021,000,0000 total
    Exercise: $2.50From: 2012-10-01Exp: 2017-12-31Common Stock (1,000,000 underlying)
  • Disposition to Issuer

    Common Stock

    2015-11-0230,0000 total
  • Disposition to Issuer

    Options to Purchase Common Stock

    2015-11-021,000,0000 total
    Exercise: $5.00From: 2012-10-01Exp: 2017-12-31Common Stock (1,000,000 underlying)
  • Disposition to Issuer

    Options to Purchase Common Stock

    2015-11-021,000,0000 total
    Exercise: $10.00From: 2012-10-01Exp: 2022-12-31Common Stock (1,000,000 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 12,290 shares of Rennova common stock.
  • [F2]Cancelled pursuant to merger agreement and related transactions between Medytox and Rennova.

Issuer

Medytox Solutions, Inc.

CIK 0001374536

Entity typeoperating

Related Parties

1
  • filerCIK 0001374536

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 12:23 PM ET
Size
11.5 KB